✦ LIBER ✦

Clinical Use of Micronized Purified Flavonoid Fraction for Treatment of Symptoms After Hemorrhoidectomy: Results of a Randomized, Controlled, Clinical Trial

✍ Scribed by F. Torre; A. P. Nicolai

Publisher: Springer
Year: 2004
Tongue: English
Weight: 116 KB
Volume: 47
Category: Article
ISSN: 0012-3706
DOI: 10.1007/s10350-003-0119-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-related quality of life after fas

✍ Ghislaine A. P. G. van Mastrigt; Manuela A. Joore; Fred H. M. Nieman; Johan L. S 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 299 KB

A randomized clinical trial of single-do

A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of wilms' tumor. Results after extended follow-up

✍ Beatriz De Camargo; Eduardo L. Franco; Brazilian Wilms' Tumor Study Group 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

for the Brazilian Wilms' Tumor Study Group$ Background. To verify the adequacy of a simplified chemotherapeutic regimen for the treatment of Wilms' tumor (WT), the authors conducted a clinical trial to compare the standard fractionated dose (15 mcg/kg x 5 days) of dactinomycin (AMD) with a single do

Comparison of myocardial perfusion by di

Comparison of myocardial perfusion by distal protection before and after primary stenting for acute myocardial infarction: Angiographic and clinical results of a randomized controlled trial

✍ Toshiya Muramatsu; Ken Kozuma; Reiko Tsukahara; Yoshiaki Ito; Naoya Fujita; Sato 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 2 views

Estrogen reduction by aromatase inhibiti

Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: Results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane

✍ Radlmaier, Albert; Eickenberg, Hans U.; Fletcher, Matthew S.; Fourcade, Richard 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 799 KB

## BACKGROUND. The concept of estrogen withdrawal by an aromatase inhibitor in the treatment of benign prostatic hyperplasia (BPH) was assessed in a prospective, randomized, double-blind, placebo-controlled multicenter trial. METHODS. Two hundred and ninety-two patients with clinical symptoms of B